Skip to content

Trending News

What Just Happened
4 years agoOptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients – Stockhouse 4 years agoOM1 Launches Multiple Sclerosis Registry with More than 20000 Patients Prospectively Followed with Deep Clinical Data – Markets Insider 4 years agoReal-World Evidence And Its Use In Advertising Of Medicinal Products In The EU And US – Media, Telecoms, IT, Entertainment – Worldwide – Mondaq News Alerts 4 years agoNational Evaluation System for health Technology Coordinating Center Adds Clinical Laboratory and Patient Engagement Expertise to Governing Committee – Business Wire 4 years agoAbnormal temperatures linked to climate change cause over 740,000 deaths annually in India
Saturday, May 10, 2025
Primary Menu
  • Categories
    • Real World Research (RWR)
    • RWD Sources
    • Movers and Shakers
    • RWE – Real World Evidence
    • Health Tech
    • Medical Devices
    • RWR & COVID 19
    • Regulatory
    • Oncology
    • Mental Health
    • Schrödinger’s Donkey
    • Decentralised Trials
    • Recently Released
  • Editorials
  • RWR
  • Newsfeed
  • FAQ
  • ABOUT
    • About RWR News
    • About the Authors
    • RWR News Editorial Policy
  • RESOURCES
    • Phoenix RWR Consulting
    • RedBird Reg Intel Tools
    • RWR Study Master File

Category: Decentralised Trials

  • Home
  • Decentralised Trials
  • Page 2
Category:
  • Decentralised Trials
  • Movers and Shakers
  • Recently Released

Syneos Health becomes Science 37’s latest partner, tapping into its virtual trial platform – FierceBiotech

CONTEXT:  Commercial announcement in decentralised trials IMPACT:  Low READ TIME:  1 min Quality Level Mean [1 – 10]:  5 1. “Syneos Health has signed up with siteless trial specialist Science Continue Reading

Posted On : April 2, 2021 Published By : Ken Ashman
Category:
  • Decentralised Trials
  • Real World Research (RWR)
  • Recently Released
  • RWE - Real World Evidence

Can a Cholesterol Drug Prevent Dementia? New Study Aims to Find Out. – Evanston RoundTable

CONTEXT:  Pragmatic Clinical Trial | Large scale studies like this, whilst technically an RCT, look and feel like RWR and with a very tangible goal in mind |  Anything to Continue Reading

Posted On : March 14, 2021 Published By : stuart.mccully
Category:
  • Decentralised Trials
  • Real World Research (RWR)
  • Recently Released
  • RWR & COVID 19

Refining, Rethinking, and Decentralizing Clinical Research – Pharmaceutical Executive

CONTEXT:  Opinion piece on the future of clinical research beyond COVID focusing on decentralised research and RWR | Embracing the concept of making clinical data more “real” (and meaningful?) by Continue Reading

Posted On : March 11, 2021 Published By : Ken Ashman
Category:
  • Decentralised Trials
  • Movers and Shakers
  • Recently Released

VirTrial and uMotif Partner to Further Expand Decentralized Clinical Trial Capabilities – PRNewswire

CONTEXT:  Commercial announcement relating to decentralised clinical trial capabilities IMPACT:  Low READ TIME:  1 min 1. “SCOTTSDALE, Ariz., March 9, 2021 /PRNewswire/ — VirTrial, the leading provider of telemedicine technology, Continue Reading

Posted On : March 11, 2021 Published By : stuart.mccully
Category:
  • Decentralised Trials
  • Health Tech
  • Recently Released

Rare disease research: are decentralised trials the future? – Clinical Trials Arena

Speculative article on decentralised trials in the COVID era.  Will they be here to stay or will the industry revert to pulling patients in for regular visits once we are Continue Reading

Posted On : March 1, 2021 Published By : stuart.mccully
Category:
  • Decentralised Trials
  • Recently Released
  • RWD Sources

Ciox Health and HealthVerity Announce Partnership to Enable First-in-Kind Decentralized Clinical Trial – PRNewswire

CONTEXT: Mostly advert for cox platform, but interesting EMR based use of RWD – stretching the definition of a decentralised study though, US Only IMPACT: RWE insights based on de-identified Continue Reading

Posted On : February 24, 2021 Published By : Mark Lorkowski
denmark
Category:
  • Decentralised Trials
  • Regulatory
  • RWR & Regulators

DE-CENTRALISED CLINICAL TRIALS = Home-based clinical trials will be possible in the future

CONEXT: Denmark | De-Centralised Trials | Regulatory Update | RWR and Regulators | RWR IMPACT: Regulator endorsed initiative for de-centralised trials|Making clinical research results more ‘real’ READ TIME: 2.5 mins Continue Reading

Posted On : February 22, 2021 Published By : stuart.mccully
Category:
  • Decentralised Trials
  • Recently Released

Contributed: Trials and tribulations – the new world of decentralized trials – Mobihealth News

EXPERT NOTES: CONTEXT:  Decentralized Clinical Trials IMPACT:  Enabling technology for ‘Decentralized Clinical Trials’ a.k.a ‘Virtual Trials’ Time Taken = 2 mins QUOTES FROM SOURCE: 1. “As mentioned earlier, COVID-19 has Continue Reading

Posted On : January 29, 2021 Published By : stuart.mccully

Posts navigation

Newer posts

XKCD Mental Break

Coffee Break Cartoon XKCD

We don’t spam! Read more in our privacy policy

Check your inbox or spam folder to confirm your signup and download

Copyright RedBird 2021
Theme: Royal Magazine by ThemeinWP
  • Cookie Policy (EU)
  • Privacy Statement (EU)
  • Impressum
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (US)
  • Cookie Policy (CA)
  • Privacy Statement (CA)
  • Disclaimer
  • Privacy Statement (US)
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}